Anixa Biosciences (ANIX)
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics program...
- Open
- 3.410
- High
- 3.494
- Low
- 3.330
- Prev. Close
- 3.490
- Volume
- 117.84K
- Turnover
- 402.79K
- Avg Price
- 3.418
- Bid/Ask Ratio
- --
- Amplitude
- 4.70%
- 52wk High
- 5.457
- Volume Ratio
- 0.25
- Turnover Ratio
- 0.37%
Anixa Biosciences Analyst Rating
View moreForecast & Rating
Jun 29, 2026Price forecast
$10.00191.55%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 12 hours ago
Anixa Biosciences to present at H.C. Wainwright Global Investment Conference
- StockTitan · 20 hours ago
Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference | ANIX Stock News
- Tip Ranks · Aug 3 at 09:09 PM
Top Executive Makes Bold Move With Fresh Anixa Biosciences Stock Buy
- PUBT · Aug 3 at 07:46 AM
Anixa Biosciences CEO Amit Kumar acquires 5,000 common shares valued at $17,350
- Market Beat · Jul 28 at 11:53 AM
Anixa Biosciences (NASDAQ:ANIX) CEO Acquires 3,000 Shares
- Tip Ranks · Jul 27 at 09:04 PM
Anixa Biosciences CEO Quietly Boosts His Stake With Fresh Insider Buys
